More recently, the use of neoadjuvant therapies has demonstrated benefit in patients with resectable stage III/IV melanoma. SWOG 1801, a phase II randomized trial, examined perioperative (neoadjuvant ...

PURPOSEAndrogen receptor signaling inhibitors (ARSIs) are mainstay treatments for metastatic prostate cancer. Hyperglycemia is a common side effect, but limited data exist on outcomes such as acute ...

Breast cancer is the most common cancer diagnosed in women, making it the second most commonly diagnosed cancer in the world. 1,2 About 2.3 million new breast cancer cases and 685,000 deaths occurred ...

The choice of wound closure modality after limb-sparing extremity soft-tissue sarcoma (eSTS) resection is fraught with uncertainty. Leveraging machine learning and clinicoradiomic data, we developed ...

The National Cancer Institute defines rare cancer as a cancer with an incidence rate <15 per 100,000 people; recently, the term “ultra-rare cancer” was defined as cancer with an incidence rate <1 × 10 ...

The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated unless otherwise noted. Relationships are self-held unless noted. I ...

Long-Term Follow-Up of E3311, an ECOG-ACRIN Cancer Research Group Phase II Trial of Transoral Surgery and Risk-Based Adjuvant Treatment in Human Papillomavirus–Initiated Oropharynx Cancer Despite ...

Transcript. Dr. Nate Pennell: Hello, and welcome to By the Book, a monthly podcast series for ASCO Education that features engaging discussions between editors and authors from the ASCO Educational ...

Artificial intelligence (AI) has the potential to transform HNSCC care by addressing critical challenges in diagnostics, prognostics, and treatment decision making. 5,6 Within AI, machine learning ...

We conducted a prospective quality improvement project within a health system, including the main tertiary, specialty, and community hospital settings. We used the electronic health record (EHR) to ...

Women are increasingly becoming a significant force in medicine, with their proportion rising from 26% in 2004 to 38% in 2022. 1 This trend extends across all medical subspecialties, with female ...

Genomic Characterization of Papillary Thyroid Cancer Reveals Germline Mutations Associated With Congenital Hypothyroidism Twenty-five patients were recruited in the study (14 male and 11 female ...